GROUP | ID NO. | VACCINE | SEROLOGICAL RESPONSES | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Binding Antibodies(log10 reciprocal titre) | Virus Neutralisation Activity(50% virus inhibition log10 titre) | |||||||||
W61D rgp120 week 50a | IIIB rgp120 DOCa | SHIVW61DDOCa |
SHIVW61D week 50a | SHIVsbgDOCa | SHIV-4 DOCa | SHIVSF33week 50a | SHIVSF33week140a | |||
A | A71 | 30μg W61D rgp120/AS02A i.m | 3.9 | 3.5 | 2.9 | <1 | 1.6 | |||
A75 | 3.9 | 3.7 | 3.1 | <1 | 1.5 | |||||
A76 | 4.2 | 3.8 | 3.1 | <1 | 1.2 | |||||
A78 | 4.1 | 3.5 | 3.2 | <1 | 1.4 | |||||
C | B234 | AS02A i.m | <1 | |||||||
B235 | <1 | |||||||||
B236 | <1 | |||||||||
B237 | <1 | |||||||||
B | A72 | 30μg W61D rgp120/AS02A i.m | 4.0 | 2.7 | 1.5 | 1.5 | ||||
A73 | 3.9 | 2.7 | 1.4 | 1.4 | ||||||
A74 | 4.0 | 2.7 | 1.5 | 1.5 | ||||||
A77 | 4.3 | 2.3 | 1.6 | 1.6 | ||||||
D | B238 | AS02A i.m | 2.4 | |||||||
B239 | >2.7 | |||||||||
B240 | 2.2 | |||||||||
B241 | >3.4 |